Costs of health services utilization of people with fetal alcohol spectrum disorder by sex and age group in Alberta, Canada.
نویسندگان
چکیده
OBJECTIVES To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex. METHODS The HSU costs of FASD including physician, outpatient, and inpatient services were described by sex and age. The costs per person-year were estimated by multiplying the average number of hospitalizations, outpatient visits, and physician visits per person-year by the average cost of each service. The annual HSU cost of FASD for Alberta was estimated by multiplying the annual HSU cost per person with FASD by the number of people living with FASD in Alberta in 2012. The lifetime HSU cost per person with FASD was estimated by sex for several lifespans ranging from 10 to 70 years. RESULTS The annual cost of HSU for people with FASD in Alberta was $259 million, of which FAS accounted for 26%. The annual HSU cost per person with FAS and FASD were $6,200 and $5,600, respectively. The incremental annual HSU cost per person with FAS is $4,100 and with FASD is $3,400 as compared to the general population. The lifetime (70 years) HSU cost per person with FAS was $506,000 and with FASD was $245,000. Males had higher HSU costs than females. HSU costs of FAS and FASD varied greatly by age group. CONCLUSION The findings suggest that FASD is a public health issue in Alberta and can be used for economic evaluations of FASD intervention and/or prevention in the province.
منابع مشابه
Incidence and prevalence of fetal alcohol spectrum disorder by sex and age group in Alberta, Canada.
OBJECTIVES To estimate incidence and prevalence of FASD by sex and age in Alberta, Canada. METHODS We included all patients recorded in the Alberta provincial health databases of inpatients, outpatients, and practitioner claims from 2003 to 2012. The number of people with FASD were calculated from available data on FAS (ICD-9 code 760.71; ICD-10 codes Q86.0 and P04.3) and estimated prevalence...
متن کاملHealth Care Burden and Cost Associated with Fetal Alcohol Syndrome: Based on Official Canadian Data
BACKGROUND Fetal Alcohol Spectrum Disorder (FASD) is a group of disorders caused by prenatal alcohol exposure. From this group, Fetal Alcohol Syndrome (FAS) is the only disorder coded in the International Classification of Diseases, version 10 (ICD-10). This coding was used to gain an understanding on the health care utilization and the mortality rate for individuals diagnosed with FAS, as well...
متن کاملThe burden of prenatal exposure to alcohol: revised measurement of cost.
BACKGROUND In Canada the incidence of Fetal Alcohol Spectrum Disorder (FASD) is estimated to be 1 in 100 live births. FASD is the leading cause of developmental and cognitive disabilities in Canada. Only one study has examined the cost of FASD in Canada. In that study we did not include prospective data for infants under the age of one year, costs for adults beyond 21 years or costs for individ...
متن کاملCosts of fetal alcohol spectrum disorder in Alberta, Canada.
BACKGROUND Although many programs targeting fetal alcohol spectrum disorder (FASD) are implemented, the province of Alberta is still lacking information on costs of FASD. OBJECTIVES To estimate the costs of FASD in Alberta based on available US and Canadian research on costs of FASD, and Alberta data. METHODS Two types of costs were estimated. The annual long-term economic cost of FASD, whi...
متن کاملThe Burden of Prenatal Exposure to Alcohol: Measurement of Cost
Background In Canada the incidence of Fetal Alcohol Spectrum Disorder (FASD) is estimated at 1 to 6 in 1000 live births. FASD is the leading cause of developmental and cognitive disabilities among Canadian children. There is a paucity of research examining the economic costs of FASD. Objective To estimate direct and indirect costs associated with FASD at the patient level. Methods Design: Cross...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique
دوره 21 3 شماره
صفحات -
تاریخ انتشار 2014